For a vaccine

Print edition : November 28, 2014

A volunteer receives a dose of the experimental vaccine “ChAd3-ZEBOV” at the University Hospital of Lausanne in Lausanne, Switzerland, on November 4. Photo: Jean-christophe Bott/AP

The WHO’s special consultation meeting in September discusses potential therapies and vaccines, but the affected countries, being poor, do not represent a “market” that can enthuse pharma companies to act fast.

    Related Articles

    This article is closed for comments.
    Please Email the Editor